Literature DB >> 7286028

Evaluation of medigoxin in outpatients.

W R Smith, E M Rodgers, P W Nicholson, R P Humm, D A Gettins, S M Dobbs, A A Deshmukh.   

Abstract

We compared our ability to predict the dose of medigoxin and of digoxin required to achieve a fixed serum concentration (the dose requirement) in 33 outpatients. Preliminary work supported the assumptions that the steady state glycoside concentration achieved was proportional to the daily dose given to an individual, and that the bioavailability of the different tablet presentations was similar for either glycoside. We were not able to predict the dose requirement from patient characteristics with any more certainty for medigoxin than for digoxin. Not only the between-patient variability in dose requirement, but also the within-patient variability, was similar for the two glycosides. However the digoxin used had a dissolution rate of over 90% in 1 h. When comparing medigoxin with digoxin of lower, or more variable dissolution rate, medigoxin may be preferable.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7286028     DOI: 10.1007/BF00562801

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  19 in total

1.  Evaluation of enzyme-multiplied immunoassay technique (EMIT) for determination of serum digoxin.

Authors:  A F Rosenthal; M G Vargas; C S Klass
Journal:  Clin Chem       Date:  1976-11       Impact factor: 8.327

2.  Equivalence of lanoxin tablets.

Authors:  S M Dobbs; E M Rodgers; B G Woodcock
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

3.  Evaluation of digoxin capsules in outpatients.

Authors:  E M Rodgers; S M Dobbs; W I Kenyon; J W Poston
Journal:  Br Med J       Date:  1977-07-23

4.  Dissolution-rates and bioavailability of digoxin tablets.

Authors:  E J Fraser; R H Leach; J W Poston; A M Bold; L S Culank; A B Lipede
Journal:  Lancet       Date:  1973-06-16       Impact factor: 79.321

5.  Rapid evaluation of creatinine clearance.

Authors:  K Siersbaek-Nielsen; J M Hansen; J Kampmann; M Kristensen
Journal:  Lancet       Date:  1971-05-29       Impact factor: 79.321

6.  Cleavage of glycosidic bonds of digoxin and derivatives as function of pH and time.

Authors:  J Kuhlmann; U Abshagen; N Rietbrock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

7.  Ideal sampling time for drug assays.

Authors:  P W Nicholson; S M Dobbs; E M Rodgers
Journal:  Br J Clin Pharmacol       Date:  1980-05       Impact factor: 4.335

8.  Digoxin intoxication: the relationship of clinical presentation to serum digoxin concentration.

Authors:  T W Smith; E Haber
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

9.  Comparison of digoxin and medigoxin in normal subjects.

Authors:  R P Hayward; H Greenwood; J Hamer
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

10.  A score for prescribing digoxin.

Authors:  P W Nicholson; S M Dobbs; A P McGill; E M Rodgers; E Slater
Journal:  Br Heart J       Date:  1978-02
View more
  1 in total

Review 1.  Serum concentration monitoring of cardiac glycosides. How helpful is it for adjusting dosage regimens?

Authors:  R J Dobbs; C J O'Neill; A A Deshmukh; P W Nicholson; S M Dobbs
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.